RxDoctor Payments DataLook up a doctor →

Celia Reyes-Acuna

Corpus Christi, TXNPI 1598712143

Payments from drug & device makers

$5,427,248in general payments, 2019–2025

Across 519 payments — averaging $10,457 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$2.5M
  • Merck$1.8M
  • Novavax Inc$584K
  • Eisai Inc.$278K
  • Sanofi Pasteur Inc.$114K
  • Pfizer$55K
  • plus $80K from 9 others
$1,533in research payments, 2019–2025

Across 5 payments — averaging $306.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novavax Inc$2K

What the payments were for

  • Food & beverage$1,320100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →